Markets-and-Money
Moderna's Cancer Vaccine Boosts Stock Amid Broader Market Sentiment
Moderna's cancer vaccine news propels stock prices, while Target is seen as a profit-taking opportunity against a backdrop of market tensions.
James McAllister • August 19, 2026
Markets-and-Money
Curaleaf's Hostile Bid for Aurora Cannabis: What It Means for Investors
Curaleaf's $4 per share bid for Aurora Cannabis signals major shifts in the cannabis market.
Marcus Rivera • Aug 18
Tech
Francisco Partners Acquires Weave Communications: A Shift in Tech Landscape
Francisco Partners is acquiring Weave Communications at $7.40 per share, highlighting a growing trend in tech sector acq…
Sarah Chen • Aug 18
Markets-and-Money
U.S. 30-Year Treasury Yields at 19-Year High: Impact on Equity Markets
As 30-year Treasury yields hit a 19-year high, equity markets face heightened volatility amid geopolitical tensions and …
James McAllister • Aug 18
Free Newsletter
Informed positions start with informed mornings.
Market-moving analysis and institutional-grade research, complimentary and delivered daily.
More Stories
Tech
Mark Cuban's FORT Robotics SPAC Deal: A New Era for Robotics Investment
Marcus Rivera • Aug 18, 2026
Markets-and-Money
Curaleaf's Hostile Takeover Bid for Aurora Cannabis: What It Means for Investors
Sarah Chen • Aug 18, 2026
US Politics
Disney's ABC vs. FCC: A Landmark First Amendment Case in Broadcasting
James McAllister • Aug 18, 2026
Defense
Raytheon Secures $22.9 Billion Pentagon Contract: What It Means for RTX Investors
James McAllister • Aug 17, 2026